BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17684148)

  • 21. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.
    Grønbaek H; Flyvbjerg A; Mellemkjaer L; Tjønneland A; Christensen J; Sørensen HT; Overvad K
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1759-64. PubMed ID: 15533904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV; Potischman N; Madigan MP; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR; Fillmore CM; Sherman ME; Brinton LA
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers.
    Stolzenberg-Solomon RZ; Limburg P; Pollak M; Taylor PR; Virtamo J; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):438-44. PubMed ID: 15006921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
    Serrano ML; Romero A; Cendales R; Sánchez-Gómez M; Bravo MM
    Biomedica; 2006 Jun; 26(2):258-68. PubMed ID: 16925098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
    Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
    Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A nested case-control study of stomach cancer and serum insulin-like growth factor (IGF)-1, IGF-2 and IGF-binding protein (IGFBP)-3.
    Pham TM; Fujino Y; Kikuchi S; Tamakoshi A; Yatsuya H; Matsuda S; Yoshimura T;
    Eur J Cancer; 2007 Jul; 43(10):1611-6. PubMed ID: 17532620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
    Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix.
    Wu X; Tortolero-Luna G; Zhao H; Phatak D; Spitz MR; Follen M
    Clin Cancer Res; 2003 Aug; 9(9):3356-61. PubMed ID: 12960122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk.
    Zhao H; Grossman HB; Spitz MR; Lerner SP; Zhang K; Wu X
    J Urol; 2003 Feb; 169(2):714-7. PubMed ID: 12544349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The expressions and clinical significance of IGFBP-2, -3 in both serum and tumor tissues in patients with epithelial ovarian cancer].
    Yan XJ; Tian Y; Wang C; Wang XL; Di JM; Cheng JX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):639-43. PubMed ID: 19764562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk.
    Nam RK; Trachtenberg J; Jewett MA; Toi A; Evans A; Emami M; Narod SA; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1270-3. PubMed ID: 15894684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
    J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor II and colorectal cancer risk in women.
    Hunt KJ; Toniolo P; Akhmedkhanov A; Lukanova A; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):901-5. PubMed ID: 12223436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
    Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study.
    Hunt KJ; Lukanova A; Rinaldi S; Lundin E; Norat T; Palmqvist R; Stattin P; Riboli E; Hallmans G; Kaaks R
    Ann Epidemiol; 2006 Jul; 16(7):563-71. PubMed ID: 16431135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
    Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
    J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.